Pfizer Inc
PFE· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|---|
| Revenue | $12.95B | $16.61B | $16.00B | $11.62B |
| Net Income | $3.21B | $3.74B | $866.00M | $2.88B |
| EPS Diluted | $0.43 |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $0.48 |
| $0.11 |
| $0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.